glioblastoma
LOH
10q (69%)
Gene amplifications
EGFR amplification (34%)
Gene inactivations
TP53 mutations (31%)
p16(INK4a) deletion (31%)
PTEN mutations (24%)
Variants
primary glioblastoma (de novo) prevailed (95%)
secondary glioblastoma
Make a note
Forum de l'article
Contact us at humpath2004@yahoo.ca if you want to be the curator of this page or this section.Copyright www.humpath.com